![](/img/cover-not-exists.png)
Phase II Trial of Proteasome Inhibitor Bortezomib in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma
Zinzani, P. L., Musuraca, G., Tani, M., Stefoni, V., Marchi, E., Fina, M., Pellegrini, C., Alinari, L., Derenzini, E., de Vivo, A., Sabattini, E., Pileri, S., Baccarani, M.Volume:
25
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/jco.2007.11.4207
Date:
August, 2007
File:
PDF, 244 KB
english, 2007